Early research (Phase 1)Study completedNCT03355196
What this trial is testing
First-in-human, Safety, Tolerability and Pharmacokinetics Study of LRX712 in Osteoarthritic Patients
Who this might be right for
Patients With Moderate Knee Osteoarthritis (30 - 65 Years)
Novartis Pharmaceuticals 42